Locations:
Search
Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran
Durability findings propel potential one-time treatment approach to phase 1b testing
Practical takeaways for the reality of overlapping cardiovascular, kidney and metabolic disease
First prospective study shows early extubation and low vasoactive/inotropic medication use
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Height-indexed aortic measurements may better identify risk than diameter alone
Insights from an expert cardiologist and a transplant surgeon
Findings promise to shape future antiplatelet drug development and treatment strategies
How and why we're offering robot-assisted options for a full array of cardiac operations
Insights on common questions from referring providers
A snapshot of key stats from one of the world's busiest centers
Advertisement
Advertisement